NeoPharm CO., LTD. (KOSDAQ: 092730)

NeoPharm CO., LTD. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	12,454	11,881	10,883	7,049	11,189	5,515
Short-Term Investments	102,876	98,026	102,000	98,000	84,000	80,000
Trading Asset Securities	-	2,083	602.5	-	992.06	-
Cash & Short-Term Investments	115,331	111,990	113,485	105,049	96,181	85,515
Cash Growth	-7.30%	-1.32%	8.03%	9.22%	12.47%	101.58%
Accounts Receivable	10,999	8,555	6,543	7,513	8,322	8,903
Other Receivables	1,609	1,809	1,103	514.09	527.14	611.62
Receivables	12,616	10,383	7,665	8,045	8,863	9,526
Inventory	14,773	10,195	8,749	7,973	8,090	5,840
Prepaid Expenses	331.51	461.05	61.34	66.55	259.57	38.53
Other Current Assets	937.41	1,474	1,309	349.62	158.57	759.97
Total Current Assets	143,989	134,502	131,270	121,484	113,551	101,680
Property, Plant & Equipment	30,166	29,244	9,341	9,743	10,121	10,496
Long-Term Investments	1,000	4,684	6,369	3,559	647.85	1,649
Other Intangible Assets	2,088	2,237	1,786	2,055	2,380	2,384
Long-Term Deferred Tax Assets	156.31	436.34	135.32	171.21	375.56	595.83
Other Long-Term Assets	6,208	6,220	6,328	6,280	5,786	5,848
Total Assets	183,747	177,459	155,347	143,408	132,978	122,742
Accounts Payable	6,019	6,435	3,703	4,347	4,194	3,174
Accrued Expenses	-	-	-	-	1.06	2.58
Short-Term Debt	-	-	-	-	-	400
Current Portion of Long-Term Debt	-	17.68	18.59	19.27	4,020	19.94
Current Portion of Leases	591.6	617.57	393.58	437.71	270.65	256.34
Current Income Taxes Payable	1,078	3,876	3,778	3,145	2,291	2,596
Current Unearned Revenue	310.32	2.24	-	-	-	-
Other Current Liabilities	5,102	5,997	5,244	4,992	4,100	6,383
Total Current Liabilities	13,101	16,945	13,137	12,941	14,877	12,831
Long-Term Debt	-	-	-	-	-	4,000
Long-Term Leases	71.14	430.05	-	101.79	19.37	-
Other Long-Term Liabilities	68.21	57.73	-	0	0	0
Total Liabilities	13,240	17,433	13,137	13,103	15,260	17,049
Common Stock	4,104	4,104	4,104	4,104	4,104	4,104
Additional Paid-In Capital	45,170	45,170	45,170	45,170	45,133	44,619
Retained Earnings	123,970	113,603	96,106	83,848	71,100	59,085
Treasury Stock	-2,679	-2,679	-2,679	-2,679	-2,679	-2,679
Comprehensive Income & Other	-57.84	-171.99	-490.33	-138.2	59.47	563.9
Shareholders' Equity	170,507	160,026	142,211	130,305	117,718	105,693
Total Liabilities & Equity	183,747	177,459	155,347	143,408	132,978	122,742
Total Debt	662.75	1,065	412.16	558.77	4,310	4,676
Net Cash (Debt)	114,668	110,925	113,073	104,490	91,871	80,839
Net Cash Growth	-7.52%	-1.90%	8.21%	13.74%	13.65%	92.52%
Net Cash Per Share	7331.13	7091.80	7229.16	6680.42	5818.13	5343.61
Filing Date Shares Outstanding	15.64	15.64	15.64	15.64	15.64	15.64
Total Common Shares Outstanding	15.64	15.64	15.64	15.64	15.64	15.64
Working Capital	130,889	117,558	118,133	108,543	98,675	88,849
Book Value Per Share	10901.09	10231.02	9092.03	8330.85	7526.09	6757.30
Tangible Book Value	168,418	157,789	140,424	128,250	115,337	103,309
Tangible Book Value Per Share	10767.57	10088.01	8977.82	8199.46	7373.90	6604.88
Land	8,554	8,554	1,202	1,223	1,286	1,286
Buildings	20,867	18,345	9,791	9,881	10,248	10,229
Machinery	9,444	8,214	6,086	6,043	5,798	5,710
Construction In Progress	273.19	1,686	-	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.